Table 2.
Characteristics of cancer survivors and non-cancer individuals from the 2010 NHIS (N=6,770)
| Cancer survivors (N=604) |
Non-cancer individuals (N=6,166) |
||
|---|---|---|---|
| Raw N (%) # | Raw N (%) # | Statistical difference | |
| Age at survey (years) | |||
| 18–44.9 | 53 (9.85) | 3,082 (51.83) | X2=276.10 (p<0.001) |
| 45–64.9 | 229 (40.27) | 2,028 (34.51) | |
| ≥65 | 322 (49.86) | 1,056 (13.65) | |
| Gender | |||
| Male | 234 (43.44) | 2,782 (48.83) | X2=4.81 (p<0.05) |
| Female | 370 (56.56) | 3,384 (51.17) | |
| Race/ethnicity | |||
| Hispanic | 49 (5.87) | 1,219 (14.78) | X2=106.29 (p<0.001) |
| Non-Hispanic White | 475 (85.63) | 3,458 (66.80) | |
| Non-Hispanic Black | 66 (6.52) | 1,048 (12.48) | |
| Non-Hispanic Asian | 10 (1.39) | 402 (5.02) | |
| Non-Hispanic other races | 4 (0.58) | 39 (0.93) | |
| Marital status | |||
| Separated | 23 (3.17) | 239 (2.62) | X2=166.67 (p<0.001) |
| Divorced | 112 (14.43) | 856 (10.57) | |
| Married | 271 (57.26) | 2,719 (53.87) | |
| Single/never married | 59 (8.31) | 1,804 (27.53) | |
| Widowed | 137 (16.84) | 523 (5.41) | |
| Education | |||
| Below high school | 87 (12.84) | 1,053 (14.16) | X2=7.49 (p=0.119) |
| High school/GED | 151 (25.45) | 1,641 (27.15) | |
| Some college | 199 (32.75) | 1,833 (30.87) | |
| Bachelor degree | 92 (15.80) | 1,071 (18.83) | |
| Graduate degree | 73 (13.16) | 540 (8.99) | |
| Number of non-cancer chronic conditions | |||
| None | 321 (54.70) | 4,722 (78.05) | X2=75.59 (p<0.001) |
| 1 | 208 (32.92) | 1,065 (16.60) | |
| 2 | 47 (8.73) | 221 (3.06) | |
| 3 | 17 (2.20) | 83 (1.20) | |
| ≥4 | 11 (1.44) | 75 (1.09) | |
| Cancer sites by human body systems | |||
| Blood/circulation | 27 (4.16) | – | |
| Bone | 7 (0.95) | – | |
| Brain | 2 (0.42) | – | |
| Breast (female only) | 127 (32.56) | – | |
| Digestive system | 60 (8.85) | – | |
| Endocrine system | 13 (2.08) | – | |
| Genitourinary system | 20 (3.41) | – | |
| Reproductive system | 165 (28.72) | – | |
| Head and neck | 5 (1.11) | – | |
| Respiratory | 19 (3.12) | – | |
| Skin | 189 (34.32) | – | |
| Soft tissue | 1 (0.27) | – | |
| Cancer-related therapy | |||
| Surgery | 391 (72.38) | – | |
| Chemotherapy | 120 (21.01) | – | |
| Radiotherapy | 105 (19.23) | – | |
| Hormonal therapy | 37 (5.90) | – | |
| Bone marrow/steam cell transplant | 2 (0.25) | – | |
| Years since cancer diagnosis | |||
| <5 | 200 (34.40) | – | |
| 5–14.9 | 233 (37.97) | – | |
| 15–24.9 | 89 (14.06) | – | |
| ≥25 | 82 (13.57) | – |
# % was weighted to reflect the entire U.S. non-institutionalized adults (N=229,377,665; ≥18 years of age) including cancer survivors (8.9%) and non-cancer individuals (91.1%).